The DOI matches its Crossref record; 400 of the 400 references it cites were found in a registry or an index.
NCCN Task Force Report: Bone Health in Cancer Care
Open accessAbstract
Bone health and maintenance of bone integrity are important components of comprehensive cancer care. Many patients with cancer are at risk for therapy-induced bone loss, with resultant osteoporotic fractures, or skeletal metastases, which may result in pathologic fractures, hypercalcemia, bone pain, and decline in motility and performance status. Effective screening and timely interventions are essential for reducing bone-related morbidity. Management of long-term bone health requires a broad knowledge base. A multidisciplinary health care team may be needed for optimal assessment and treatment of bone-related issues in patients with cancer. Since publication of the previous NCCN Task Force Report: Bone Health in Cancer Care in 2009, new data have emerged on bone health and treatment, prompting NCCN to convene this multidisciplinary task force to discuss the progress made in optimizing bone health in patients with cancer. In December 2012, the panel members provided didactic presentations on various topics, integrating expert judgment with a review of the key literature. This report summarizes issues surrounding bone health in cancer care presented and discussed during this NCCN Bone Health in Cancer Care Task Force meeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 400
Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer
Walsh, P. C. (2005) · Journal of Urology · doi:10.1016/s0022-5347(05)60500-9 · Cited by 315
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115858.45890.53 · Cited by 315
Geisler, J., King, N. C., Anker, G. B., Ornati, G., di Salle, E., Lønning, P. E., & Dowsett, M. (1998) · PubMed · Cited by 314
MAILLEFERT, J. F., SIBILIA, J., MICHEL, F., SAUSSINE, C., JAVIER, R. M., & TAVERNIER, C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61639-2 · Cited by 308
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., & Papapoulos, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118841 · Cited by 305
Greenspan, S. L., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-6-200703200-00006 · Cited by 302
Effect of feeding on bone turnover markers and its impact on biological variability of measurements
Clowes, J. A., Hannon, R. A., Yap, T. S., Hoyle, N. R., Blumsohn, A., & Eastell, R. (2002) · Bone · doi:10.1016/s8756-3282(02)00728-7 · Cited by 296
Nelson, H. D., Helfand, M., Woolf, S. H., & Allan, J. D. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00015 · Cited by 295
Dehdashti, F., Flanagan, F. L., Mortimer, J. E., Katzenellenbogen, J. A., Welch, M. J., & Siegel, B. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050359 · Cited by 290
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Shea, B., Wells, G., Adachi, J., Waldegger, L., Guyatt, G., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-6002 · Cited by 286
Chesnut, C. H., Bell, N. H., Clark, G. S., Drinkwater, B. L., English, S. C., Johnston, C. C., Notelovitz, M., Rosen, C., Cain, D. F., Flessland, K. A., et al. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00387-7 · Cited by 282
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-3-201208070-00462 · Cited by 282
Eidtmann, H., de Boer, R., Bundred, N., Llombart-Cussac, A., Davidson, N., Neven, P., von Minckwitz, G., Miller, J., Schenk, N., & Coleman, R. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq217 · Cited by 281
Logothetis, C. J., Basch, E., Molina, A., Fizazi, K., North, S. A., Chi, K. N., Jones, R. J., Goodman, O. B., Mainwaring, P. N., Sternberg, C. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70473-4 · Cited by 280
Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
Mellström, D., Vandenput, L., Mallmin, H., Holmberg, A. H., Lorentzon, M., Odén, A., Johansson, H., Orwoll, E. S., Labrie, F., Karlsson, M. K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080518 · Cited by 279
(BONE), F. T. O. I. O. V. F. T. I. N. A. A. E., Delmas, P. D., Recker, R. R., Chesnut, C. H., Skag, A., Stakkestad, J. A., Emkey, R., Gilbride, J., Schimmer, R. C., & Christiansen, C. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1602-9 · Cited by 279
Delmas, P. D., Balena, R., Confravreux, E., Hardouin, C., Hardy, P., & Bremond, A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.955 · Cited by 278
Bone Loss following Hypogonadism in Men with Prostate Cancer Treated with GnRH Analogs
Mittan, D. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3656 · Cited by 278
Giuliano, A. E., Hawes, D., Ballman, K. V., Whitworth, P. W., Blumencranz, P. W., Reintgen, D. S., Morrow, M., Leitch, A. M., Hunt, K. K., McCall, L. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1034 · Cited by 276
Armstrong, A. J., Garrett-Mayer, E., Ou Yang, Y.-C., Carducci, M. A., Tannock, I., de Wit, R., & Eisenberger, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4769 · Cited by 275
Radiation exposure in bone mineral density assessment
Njeh, C. F., Fuerst, T., Hans, D., Blake, G. M., & Genant, H. K. (1999) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00026-8 · Cited by 274
Conte, P. F., Latreille, J., Mauriac, L., Calabresi, F., Santos, R., Campos, D., Bonneterre, J., Francini, G., & Ford, J. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2552 · Cited by 268
Saarto, T., Blomqvist, C., Välimäki, M., Mäkelä, P., Sarna, S., & Elomaa, I. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1341 · Cited by 265
Raisz, L. G. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042092 · Cited by 262
A high incidence of vertebral fracture in women with breast cancer
Kanis, J. A., McCloskey, E. V., Powles, T., Paterson, A. H. G., Ashley, S., & Spector, T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690188 · Cited by 258
Chen, Z. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.552 · Cited by 258
Goss, P. E., Ingle, J. N., Pritchard, K. I., Ellis, M. J., Sledge, G. W., Budd, G. T., Rabaglio, M., Ansari, R. H., Johnson, D. B., Tozer, R., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.7805 · Cited by 255
Estimated number of prevalent cases of metastatic bone disease in the US adult population
Arneson, T. J., Li, S., Peng, Y., Weinhandl, E. D., Blaes, A., Cetin, K., Chia, V. M., Stryker, S., Pinzone, J. J., & Acquavella, J. (2012) · Clinical Epidemiology · doi:10.2147/clep.s28339 · Cited by 250
Smith, M. R., Fallon, M. A., Lee, H., & Finkelstein, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032058 · Cited by 248
Long-term Risk of Incident Vertebral Fractures
Cauley, J. A., Hochberg, M. C., Lui, L.-Y., Palermo, L., Ensrud, K. E., Hillier, T. A., Nevitt, M. C., & Cummings, S. R. (2007) · JAMA · doi:10.1001/jama.298.23.2761 · Cited by 248
Ernst, D. S., Tannock, I. F., Winquist, E. W., Venner, P. M., Reyno, L., Moore, M. J., Chi, K., Ding, K., Elliott, C., & Parulekar, W. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.042 · Cited by 247
Diamond, T., Campbell, J., Bryant, C., & Lynch, W. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8<1561::aid-cncr11>3.0.co;2-z · Cited by 246
Fatalities and Injuries From Falls Among Older Adults—United States, 1993-2003 and 2001-2005
(2007) · JAMA · doi:10.1001/jama.297.1.32 · Cited by 244
Janni, W., Vogl, F. D., Wiedswang, G., Synnestvedt, M., Fehm, T., Jückstock, J., Borgen, E., Rack, B., Braun, S., Sommer, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2515 · Cited by 242
Primary Care for Survivors of Breast Cancer
Burstein, H. J., & Winer, E. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431506 · Cited by 241
Vitamin D status and response to treatment in post-menopausal osteoporosis
Adami, S., Giannini, S., Bianchi, G., Sinigaglia, L., Di Munno, O., Fiore, C. E., Minisola, S., & Rossini, M. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0650-y · Cited by 237
Dearnaley, D. P. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg038 · Cited by 234
Christodoulou, C., Pervena, A., Klouvas, G., Galani, E., Falagas, M. E., Tsakalos, G., Visvikis, A., Nikolakopoulou, A., Acholos, V., Karapanagiotidis, G., et al. (2009) · Oncology · doi:10.1159/000201931 · Cited by 232
Van der Linden, Y. M., Dijkstra, P. D. S., Kroon, H. M., Lok, J. J., Noordijk, E. M., Leer, J. W. H., & Marijnen, C. A. M. (2004) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.86b4.14703 · Cited by 232
Orwoll, E., Teglbjærg, C. S., Langdahl, B. L., Chapurlat, R., Czerwinski, E., Kendler, D. L., Reginster, J.-Y., Kivitz, A., Lewiecki, E. M., Miller, P. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1569 · Cited by 232
Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review
Parker, M. J., Gillespie, W. J., & Gillespie, L. D. (2006) · BMJ · doi:10.1136/bmj.38753.375324.7c · Cited by 228
Daubine, F., Le Gall, C., Gasser, J., Green, J., & Clezardin, P. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk054 · Cited by 226
van den Hout, W. B., van der Linden, Y. M., Steenland, E., Wiggenraad, R. G. J., Kievit, J., de Haes, H., & Leer, J. W. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.222 · Cited by 226
Sathiakumar, N., Delzell, E., Morrisey, M. A., Falkson, C., Yong, M., Chia, V, Blackburn, J., Arora, T., & Kilgore, M. L. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.7 · Cited by 221
Bundred, N. J., Campbell, I. D., Davidson, N., DeBoer, R. H., Eidtmann, H., Monnier, A., Neven, P., von Minckwitz, G., Miller, J. C., Schenk, N. L., et al. (2008) · Cancer · doi:10.1002/cncr.23259 · Cited by 218
Brufsky, A. M., Bosserman, L. D., Caradonna, R. R., Haley, B. B., Jones, C. M., Moore, H. C. F., Jin, L., Warsi, G. M., Ericson, S. G., & Perez, E. A. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.n.015 · Cited by 214
Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
Smith, M. R., Boyce, S. P., Moyneur, E., Duh, M. S., Raut, M. K., & Brandman, J. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00033-9 · Cited by 212
Serum Bone Alkaline Phosphatase and Calcaneus Bone Density Predict Fractures: A Prospective Study
Ross, P. D., Kress, B. C., Parson, R. E., Wasnich, R. D., Armour, K. A., & Mizrahi, I. A. (2000) · Osteoporosis International · doi:10.1007/s001980050009 · Cited by 207
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
Costa, L., Badia, X., Chow, E., Lipton, A., & Wardley, A. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0418-0 · Cited by 206
Bone Matters: Are Density Increases Necessary to Reduce Fracture Risk?
Faulkner, K. G. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.183 · Cited by 205
Dearnaley, D. P., Mason, M. D., Parmar, M. K., Sanders, K., & Sydes, M. R. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70201-3 · Cited by 204
A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden
Le Gall, C., Bellahcène, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3940 · Cited by 204
Kalantaridou, S. N., Davis, S. R., & Nelson, L. M. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70051-7 · Cited by 201
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
Christgau, S., Bitsch-Jensen, O., Hanover Bjarnason, N., Gamwell Henriksen, E., Qvist, P., Alexandersen, P., & Bang Henriksen, D. (2000) · Bone · doi:10.1016/s8756-3282(00)00248-9 · Cited by 200
(2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200211000-00019 · Cited by 196
Paterson, A. H., Anderson, S. J., Lembersky, B. C., Fehrenbacher, L., Falkson, C. I., King, K. M., Weir, L. M., Brufsky, A. M., Dakhil, S., Lad, T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70226-7 · Cited by 194
Self-citationVertebral Fractures in Osteoporosis
Genant, H. K., Li, J., Wu, C. Y., & Shepherd, J. A. (2000) · Journal of Clinical Densitometry · doi:10.1385/jcd:3:3:281 · Cited by 193
Pain Predicts Overall Survival in Men With Metastatic Castration-Refractory Prostate Cancer
Halabi, S., Vogelzang, N. J., Kornblith, A. B., Ou, S.-S., Kantoff, P. W., Dawson, N. A., & Small, E. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0367 · Cited by 193
Callstrom, M. R., Charboneau, J. W., Goetz, M. P., Rubin, J., Atwell, T. D., Farrell, M. A., Welch, T. J., & Maus, T. P. (2006) · Skeletal Radiology · doi:10.1007/s00256-005-0003-2 · Cited by 192
Body, J.-J., Diel, I. J., Bell, R., Pecherstorfer, M., Lichinitser, M. R., Lazarev, A. F., Tripathy, D., & Bergström, B. (2004) · Pain · doi:10.1016/j.pain.2004.07.011 · Cited by 190
Diamond, T. H., Winters, J., Smith, A., De Souza, P., Kersley, J. H., Lynch, W. J., & Bryant, C. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1444::aid-cncr1468>3.0.co;2-m · Cited by 190
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis
Costelloe, C. M., Rohren, E. M., Madewell, J. E., Hamaoka, T., Theriault, R. L., Yu, T.-K., Lewis, V. O., Ma, J., Stafford, R. J., Tari, A. M., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70088-9 · Cited by 189
Lester, J. E., Dodwell, D., Purohit, O. P., Gutcher, S. A., Ellis, S. P., Thorpe, R., Horsman, J. M., Brown, J. E., Hannon, R. A., & Coleman, R. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5101 · Cited by 189
Giusti, A., Hamdy, N. A. T., Dekkers, O. M., Ramautar, S. R., Dijkstra, S., & Papapoulos, S. E. (2011) · Bone · doi:10.1016/j.bone.2010.12.033 · Cited by 187
Three Monthly Intravenous Injections of Ibandronate in the Treatment of Postmenopausal Osteoporosis
Thiébaud, D., Burckhardt, P., Kriegbaum, H., Huss, H., Mulder, H., Juttmann, J. R., & Schöter, K. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00249-0 · Cited by 186
Unusual mid‐shaft fractures during long‐term bisphosphonate therapy
Odvina, C. V., Levy, S., Rao, S., Zerwekh, J. E., & Rao, D. S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03581.x · Cited by 186
Wiedswang, G., Borgen, E., Kåresen, R., Qvist, H., Janbu, J., Kvalheim, G., Nesland, J. M., & Naume, B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0245 · Cited by 185
Weitzman, R., Sauter, N., Eriksen, E. F., Tarassoff, P. G., Lacerna, L. V., Dias, R., Altmeyer, A., Csermak-Renner, K., McGrath, L., Lantwicki, L., et al. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.12.005 · Cited by 185
Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
Bruning, P., Pit, M., de Jong-Bakker, M., van den Ende, A., Hart, A., & van Enk, A. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.58 · Cited by 180
The Scottish Cancer Trials Breast Group, Stewart, H., Forrest, A., Everington, D., McDonald, C., Dewar, J., Hawkins, R., Prescott, R., & George, W. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.356 · Cited by 177
Brufsky, A., Bundred, N., Coleman, R., Lambert-Falls, R., Mena, R., Hadji, P., Jin, L., Schenk, N., Ericson, S., & Perez, E. A. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0206 · Cited by 175
Kiratli, B. J., Srinivas, S., Perkash, I., & Terris, M. K. (2001) · Urology · doi:10.1016/s0090-4295(00)00895-5 · Cited by 172
Self-citationVehmanen, L., Elomaa, I., Blomqvist, C., & Saarto, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3515 · Cited by 168
Ettinger, B., Black, D. M., Mitlak, B. H., Knickerbocker, R. K., Nickelsen, T., Genant, H. K., Christiansen, C., Delmas, P. D., Zanchetta, J. R., Stakkestad, J., et al. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200001000-00021 · Cited by 168
Molecular Mechanisms of Breast Cancer Metastases to Bone
Guise, T. A., Kozlow, W. M., Heras-Herzig, A., Padalecki, S. S., Yin, J. J., & Chirgwin, J. M. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.s.004 · Cited by 167
Maxon, H. R., Schroder, L. E., Hertzberg, V., Thomas, S. R., Englaro, E., Samaratunga, R. C., Smith, H., Moulton, J. S., Williams, C. C., & Ehrhardt, G. J. (1991) · PubMed · Cited by 166
Diel, I. J., Body, J.-J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.025 · Cited by 166
Incidence and demography of femur fractures with and without atypical features
Feldstein, A. C., Black, D., Perrin, N., Rosales, A. G., Friess, D., Boardman, D., Dell, R., Santora, A., Chandler, J. M., Rix, M. M., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1550 · Cited by 166
Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer
Cook, R. J., Coleman, R. E., Brown, J. E., Lipton, A., Major, P. P., Hei, Y. J., Fred Saad, C., & Smith, M. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0269 · Cited by 161
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Smith, M. R., Morton, R. A., Barnette, K. G., Sieber, P. R., Malkowicz, S. B., Rodriguez, D., Hancock, M. L., & Steiner, M. S. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.016 · Cited by 160
Powles, T. J., Ashley, S., Tidy, V. A., Nevantaus, A., McCloskey, E., Kanis, J. A., Paterson, A. H. G., & Rosenqvist, K. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.704 · Cited by 159
Estilo, C. L., Van Poznak, C. H., Wiliams, T., Bohle, G. C., Lwin, P. T., Zhou, Q., Riedel, E. R., Carlson, D. L., Schoder, H., Farooki, A., et al. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0091 · Cited by 158
Self-citationContemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer
Meng, M. V., Grossfeld, G. D., Sadetsky, N., Mehta, S. S., Lubeck, D. P., & Carroll, P. R. (2002) · Urology · doi:10.1016/s0090-4295(02)01560-1 · Cited by 156
Crew, K. D., Shane, E. J., Cremers, S., McMahon, D. J., Irani, D., & Hershman, D. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6162 · Cited by 155
Hirsh, V., Major, P. P., Lipton, A., Cook, R. J., Langer, C. J., Smith, M. R., Brown, J. E., & Coleman, R. E. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181651c0e · Cited by 155
Hershman, D. L., McMahon, D. J., Crew, K. D., Cremers, S., Irani, D., Cucchiara, G., Brafman, L., & Shane, E. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4707 · Cited by 153
Vertebral Fracture Assessment: The 2005 ISCD Official Positions
Vokes, T., Bachman, D. M., Baim, S., Binkley, N., Broy, S. B., Ferrar, L., Lewiecki, E. M., Richmond, B. J., & Schousboe, J. T. (2006) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2006.05.006 · Cited by 151
Wardley, A. M., Davidson, N. G. P., Barrett-Lee, P. J., Hong, A., Mansi, J., Dodwell, D. J., Murphy, R., Mason, T., & Cameron, D. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602551 · Cited by 151
Ravn, P., Clemmesen, B., & Christiansen, C. (1999) · Bone · doi:10.1016/s8756-3282(98)00183-5 · Cited by 148
Lee, H., McGovern, K., Finkelstein, J. S., & Smith, M. R. (2005) · Cancer · doi:10.1002/cncr.21381 · Cited by 148
Dai, J., Kitagawa, Y., Zhang, J., Yao, Z., Mizokami, A., Cheng, S., Nor, J. E., McCauley, L. K., Taichman, R. S., & Keller, E. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1382 · Cited by 147
Vitamin D and Calcium to Prevent Hip Fractures in Elderly Women
Chapuy, M. C., ARLOT, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S. B., Delmas, P. D., & Meunier, P. J. (1993) · The Endocrinologist · doi:10.1097/00019616-199303000-00021 · Cited by 145
Shane, E. J., Burr, D. B., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R. M., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.416 · Cited by 144
Tumor–stroma co-evolution in prostate cancer progression and metastasis
Josson, S., Matsuoka, Y., Chung, L. W. K., Zhau, H. E., & Wang, R. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.11.016 · Cited by 141
The cost of treating skeletal-related events in patients with prostate cancer.
Lage, M. J., Barber, B., Harrison, D. J., & Sun, J. (2008) · PubMed · Cited by 140
Markers of bone resorption in patients treated with pamidronate
Lipton, A., Demers, L., Curley, E., Chinchilli, V. M., Gaydos, L. J., Hortobágyi, G. N., Theriault, R. L., Clemens, D., Costa, L., Seaman, J. J., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00277-9 · Cited by 139
Llombart‐Cussac, A., Frassoldati, A., Paija, O., Sleeboom, H. P., Jérusalem, G., Mebis, J., Deleu, I., Miller, J. C., Schenk, N., & Neven, P. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.08.002 · Cited by 136
Aragon‐Ching, J. B., Ning, Y. M., Chen, C. C., Latham, L. L., Guadagnini, J.-P., Gulley, J. L., Arlen, P. M., Wright, J. J., Parnes, H. L., Figg, W. D., et al. (2009) · Cancer Investigation · doi:10.1080/07357900802208608 · Cited by 134
Pockett, R. D., Castellano, D., McEwan, P. C., Oglesby, A. K., Barber, B., & Chung, K. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2009.01135.x · Cited by 131
Sathiakumar, N., Delzell, E., Morrisey, M. A., Falkson, C. I., Yong, M., Chia, V., Blackburn, J. L., Arora, T., Brill, I. K., & Kilgore, M. L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1721-x · Cited by 131
Senaratne, S. G., Mansi, J., & Colston, K. W. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600297 · Cited by 129
Clinical correlates of atypical femoral fracture
Lo, J. C.-M., Huang, S. Y., Lee, G. A., Khandewal, S., Provus, J., Ettinger, B. B., Gonzalez, J. R., Hui, R. L., & Grimsrud, C. D. (2012) · Bone · doi:10.1016/j.bone.2012.02.632 · Cited by 124
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Smith, M. R., Morton, R. A., Barnette, K. G., SIEBER, P. R., Malkowicz, S. B., Rodriguez, D., Hancock, M. L., & Steiner, M. S. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.06.022 · Cited by 124
An Approach to Identifying Osteopenic Women at Increased Short-term Risk of Fracture
Miller, P. D., Barlas, S., Brenneman, S. K., Abbott, T. A., Chen, Y.-T., Barrett-Connor, E. L., & Siris, E. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1113 · Cited by 122
The effect of vitamin D on falls: a meta-analysis
Zhang, Q. (2013) · Chinese Journal of Osteoporosis and Bone Mineral Research · Cited by 120
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., Price, D., SIEBER, P. R., Barnette, K. G., Rodriguez, D., & Steiner, M. S. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.08.137 · Cited by 118
Adams, J. S., Kantorovich, V., Wu, C., Javanbakht, M., & Hollis, B. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5899 · Cited by 114
Thiébaud, D., Burckhardt, P., Melchior, J., Eckert, P., Jacquet, A. F., Schnyder, P., & Gobelet, C. (1994) · Osteoporosis International · doi:10.1007/bf01623227 · Cited by 112
Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy
Simpson, E. R., & Dowsett, M. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.317 · Cited by 112
Roudier, M. P., Vesselle, H. J., True, L. D., Higano, C. S., Ott, S. M., King, S. H., & Vessella, R. L. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022627421000 · Cited by 111
Hayashi, T., Hideshima, T., Nguyen, A. N., Munoz, O., Podar, K., Hamasaki, M., Ishitsuka, K., Yasui, H., Richardson, P., Chakravarty, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0632 · Cited by 110
Smith, M. R., Fred Saad, C., Egerdie, B., Szwedowski, M., Tammela, T. L. J., Ke, C., Leder, B. Z., & Goessl, C. D. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.08.048 · Cited by 109
Higano, C. S. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0995 · Cited by 109
Fogelman, I., Blake, G. M., Blamey, R. W., Palmer, M. K., Sauerbrei, W., Schumacher, M. C., Serin, D., Stewart, A., & Wilpshaar, W. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1508-y · Cited by 109
Mason, M. D., Sydes, M. R., Glaholm, J., Langley, R. E., Huddart, R. A., Sokal, M., STOTT, M., Robinson, A. C. R., James, N. D., Parmar, M., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk178 · Cited by 108
Does This Woman Have Osteoporosis?
Green, A. D. (2004) · JAMA · doi:10.1001/jama.292.23.2890 · Cited by 107
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women
Chapuy, M. C., ARLOT, M. E., Duboeuf, F., BRUN, J., Crouzet, B., Arnaud, S., Delmas, P. D., & Meunier, P. J. (1993) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199305000-00026 · Cited by 107
Prevalent Vertebral Fractures in Black Women and White Women
Cauley, J. A., Palermo, L., Vogt, M. T., Ensrud, K. E., Ewing, S. K., Hochberg, M. C., Nevitt, M. C., & Black, D. M. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080411 · Cited by 106
Body, J. J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Reginster, J., Rozenberg, S., & Kaufman, J. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0439-4 · Cited by 105
Shapiro, C. L., Halabi, S., Hárs, V., Archer, L. E., Weckstein, D. J., Kirshner, J. J., Sikov, W. M., Winer, E. P., Burstein, H. J., Hudis, C. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.024 · Cited by 102
Bisphosphonate-Related Osteonecrosis of the Jaw: Diagnosis, Prevention, and Management
Ruggiero, S. L., & Mehrotra, B. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.60.063007.134350 · Cited by 101
Meta-Analyses of Therapies for Postmenopausal Osteoporosis
The Osteoporosis Methodology Group (2002) · Endocrine Reviews · doi:10.1210/er.2001-1002 · Cited by 99
Fuleihan, G. E., Salamoun, M., Mourad, Y. A., Chehal, A. A., Salem, Z. M. K., Mahfoud, Z. R., & Shamseddine, A. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1444 · Cited by 99
Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study.
Robertson, A. G., Reed, N. S., & Ralston, S. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2427 · Cited by 99
Zeng, L., Chow, E., Bedard, G., Zhang, L., Fairchild, A. M., Vassiliou, V., El‐Din, M. A. A., Jesús-García, R., Kumar, A. A., Forges, F., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.028 · Cited by 96
Kyphoplasty Enhances Function and Structural Alignment in Multiple Myeloma
Lane, J. M., Hong, R., Koob, J., Kiechle, T., Niesvizky, R., Pearse, R. N., Siegel, D. S. D., & Poynton, A. R. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000131642.96984.74 · Cited by 95
Rosen, C. J., & Gallagher, J. C. (2011) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2011.03.004 · Cited by 95
Eastell, R., Mallinak, N. J. S., Weiss, S., Ettinger, M. P., Pettinger, M. B., Cain, D. F., Flessland, K. A., & Chesnut, C. H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.594 · Cited by 94
Yu, E. Y., Massard, C., Gross, M. E., Carducci, M. A., Culine, S., Hudes, G. R., Posadas, E. M., Sternberg, C. N., Wilding, G., Trudel, G. C., et al. (2011) · Urology · doi:10.1016/j.urology.2011.01.006 · Cited by 90
Significance and impact of bisphosphonate-induced acute phase responses
Olson, K. B., & Poznak, C. H. V. (2007) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155207080806 · Cited by 87
Hines, S. L., Mincey, B. A., Sloan, J. A., Thomas, S. P., Chottiner, E. G., Loprinzi, C. L., Carlson, M. D., Atherton, P. J., Salim, M., & Perez, E. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1783 · Cited by 86
Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial
Eastell, R., Adams, J. E., Clack, G., Howell, A., Cuzick, J. M., Mackey, J. R., Beckmann, M. W., & Coleman, R. E. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq541 · Cited by 86
Greenspan, S. L., Nelson, J. B., Trump, D. L., Wagner, J. M., Miller, M. E., Perera, S., & Resnick, N. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1233 · Cited by 85
Buclin, T., Rochat, M. C., Burckhardt, P., Azria, M., & Attinger, M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1478 · Cited by 84
Adams, J. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2729 · Cited by 84
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
Papachristou, D. J., Basdra, E. K., & Papavassiliou, A. G. (2010) · Medicinal Research Reviews · doi:10.1002/med.20224 · Cited by 81
Kasalický, J., & Krajská, V. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050309 · Cited by 81
Gallo, M., Luca, A. D., Lamura, L., & Normanno, N. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr159 · Cited by 81
Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid
Brown, J. E., Ellis, S. P., Lester, J., Gutcher, S. A., Khanna, T., Purohit, O. P.-K., McCloskey, E. V., & Coleman, R. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0247 · Cited by 80
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., SIEBER, P. R., Barnette, K. G., Rodriquez, D., & Steiner, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5517 · Cited by 80
Neto, A. S., Tobias‐Machado, M., Esteves, M. A., Senra, M. D., Wroclawski, M. L., Fonseca, F. L. A., dos Reis, R. B., Pompeo, A. C. L., & del Giglio, A. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.4 · Cited by 79
Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence
Rabenda, V., Hiligsmann, M., & Reginster, J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903140533 · Cited by 78
Tennis, P. S., Rothman, K. J., Bohn, R. L., Tan, H., Zavras, A. I., Laskarides, C., Calingaert, B., & Anthony, M. S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3292 · Cited by 77
Skeletal metastases in advanced prostate cancer: cell biology and therapy
Koutsilieris, M. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00122-a · Cited by 73
Pamidronate Reduces Bone Loss after Allogeneic Stem Cell Transplantation
Grigg, A., Shuttleworth, P., Reynolds, J., SCHWARER, A. P., Szer, J., Bradstock, K. F., Hui, C., Herrmann, R., & Ebeling, P. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0684 · Cited by 70
Circadian Variation in Serum CrossLaps Concentration Is Reduced in Fasting Individuals
Christgau, S. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.3.431a · Cited by 70
Tauchmanovà, L., Colao, A. A. L., Lombardi, G., Rotoli, B., & Selleri, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2870 · Cited by 69
Galvao, D. A., Taaffe, D. R., Cormie, P., Spry, N. A., Chambers, S. K., Peddle‐McIntyre, C. J., Baker, M. K., Denham, J. W., Joseph, D. J., Groom, G., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-517 · Cited by 69
Zelinka, T., Timmers, H. J. L. M., Kozupa, A., Chen, C. C., Carrasquillo, J. A., Reynolds, J. C., Ling, A. L., Eisenhofer, G., Lazúrová, I., Adams, K. T., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0217 · Cited by 67
Kibel, A. S. (2011) · Yearbook of Urology · doi:10.1016/j.yuro.2011.06.011 · Cited by 66
Wade, S. W., Curtis, J. R., Yu, J., White, J., Stolshek, B. S., Merinar, C., Balasubramanian, A., Kallich, J. D., Adams, J., & Viswanathan, H. N. (2012) · Bone · doi:10.1016/j.bone.2011.12.021 · Cited by 64
Geisler, J., & Lønning, P. E. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.015 · Cited by 64
Sawka, A. M., Boulos, P., BEATTIE, K. A., Παπαϊωάννου, Α., Gafni, A., Cranney, A., Hanley, D. A., Adachi, J. D., Papadimitropoulos, E., & Thabane, L. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.07.006 · Cited by 64
Effects of Raloxifene After Tamoxifen on Breast and Endometrial Tumor Growth in Athymic Mice
O'Regan, R. M., Gajdos, C., Dardes, R. C., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.274 · Cited by 64
Endothelin Inhibition: Novel Therapy for Prostate Cancer
Nelson, J. B. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000096372.07687.86 · Cited by 62
Bhoopalam, N., Campbell, S. C., MORITZ, T. E., Broderick, W. R., Iyer, P., Arcenas, A. G., Veldhuizen, P. J. V., FRIEDMAN, N. C., Reda, D. J., Warren, S. R., et al. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.07.046 · Cited by 62
Tauchmanovà, L., SIMONE, G. D., Musella, T., Orio, F., Ricci, P., Nappi, C., Lombardi, G., Colao, A. A. L., Rotoli, B., & Selleri, C. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705196 · Cited by 62
Denton, C. P., Lindahl, G. E., Khan, K., Shiwen, X., Ong, V. H., Gaspar, N. J., Lazaridis, K., Edwards, D. R., Leask, A., Eastwood, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413134200 · Cited by 61
Lee, B., Franklin, I., Lewis, J. S., Coombes, R. C., Leonard, R. C., Gishen, P., & Stebbing, J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.021 · Cited by 59
Camacho, P. M., Dayal, A. S., Diaz, J., Nabhan, F. A., Agarwal, M., Norton, J., Robinson, P. A., & Albain, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7451 · Cited by 59
Bisphosphonates and metastatic breast carcinoma
Lipton, A. (2003) · Cancer · doi:10.1002/cncr.11123 · Cited by 58
Xie, J., Namjoshi, M. A., Wu, E. Q., Parikh, K., Diener, M. D., Yu, A. P., Guo, A. X., & Culver, K. W. (2011) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2011.17.8.621 · Cited by 58
Wilkinson, G. S., Baillargeon, J., Kuo, Y., Freeman, J. L., & Goodwin, J. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7524 · Cited by 58
Hershman, D. L., McMahon, D. J., Crew, K. D., Shao, T. H., Cremers, S., Brafman, L., Awad, D., & Shane, E. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1366 · Cited by 57
Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use
Goddard, M. S., Reid, K. R., Johnston, J. C., & Khanuja, H. S. (2009) · Orthopedics · doi:10.3928/01477447-20090624-27 · Cited by 56
Estrogenic side effects of androgen deprivation therapy.
Guise, T. A., Oefelein, M. G., Eastham, J. A., Cookson, M. S., Higano, C. S., & Smith, M. R. (2007) · Europe PMC (PubMed Central) · Cited by 53
Breen, T. L., & Shane, E. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.013 · Cited by 53
Clarke, B. L. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00343-9 · Cited by 53
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett‐Connor, E., Mosca, L. J., Collins, P. D., Geiger, M. J., Grady, D. G., Kornitzer, M., McNabb, M. A., & WENGER, N. K. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000248825.32323.b3 · Cited by 51
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Clarke, B. L. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79521-4 · Cited by 51
Cancer Treatment–Related Bone Loss: A Review and Synthesis of the Literature
Khan, M. N., & Khan, A. A. (2008) · Current Oncology · doi:10.3747/co.2008.174 · Cited by 50
Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
Poznak, C. H. V., & Estilo, C. L. (2006) · PubMed · Cited by 47
Mitri, Z. I., Nanda, R., Blackwell, K., Costelloe, C. M., Hood, I., Wei, C., Brewster, A. M., Ibrahim, N. K., Koenig, K. B., Hortobágyi, G. N., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2845 · Cited by 45
Strontium-89--precursor targeted therapy for pain relief of blastic metastatic disease
Robinson, R. G. (1993) · Cancer · Cited by 42
Morrow, M. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70081-6 · Cited by 40
Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures
Sheehy, O., Kindundu, C., Barbeau, M., & LeLorier, J. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0829-2 · Cited by 39
Lee, C. E., Leslie, W. D., Czaykowski, P., Gingerich, J., Geirnaert, M., & Lau, Y.-K. (2011) · Current Oncology · doi:10.3747/co.v18i4.746 · Cited by 35
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Wenz, F. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090558 · Cited by 35
Baum, M., Buzdar, A. U., Cuzick, J. M., Forbes, J., Houghton, J., Howell, A., Sahmoud, T., & ATAC (Arimidex, T. A. O. I. C. T. G. (2003) · UCL Discovery (University College London) · Cited by 34
1–2 Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Bevers, T. B. (2007) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(07)80007-5 · Cited by 31
Eng‐Wong, J., Reynolds, J. C., Venzon, D. J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2827 · Cited by 31
Impact of aromatase inhibitors on bone health in breast cancer patients
Geisler, J., & Lønning, P. E. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.10.004 · Cited by 30
Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement
Pfister, A. K., Welch, C. W., & Emmett, M. K. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-4-201108160-00020 · Cited by 29
Safety of aromatase inhibitors in the adjuvant setting
Perez, E. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9704-7 · Cited by 29
Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
Smith, M. R., Boyce, S. P., Moyneur, É., Duh, M. S., Raut, M. K., & Brandman, J. (2006) · The Journal of Urology · doi:10.1097/00005392-200601000-00035 · Cited by 25
Swenson, K. K., Henly, S. J., Shapiro, A. C., & Schroeder, L. M. (2005) · Clinical journal of oncology nursing · doi:10.1188/05.cjon.177-184 · Cited by 20
Hennekens, C. H., & Barice, E. J. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.05.001 · Cited by 19
The role of hormone replacement therapy in the management of premature ovarian failure
Christin‐Maître, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0699 · Cited by 17
Weycker, D. A., Lamerato, L. E., Schooley, S., Macarios, D., Woodworth, T., Yurgin, N., & Oster, G. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2108-5 · Cited by 16
Kuet, K.-P., Charlesworth, D., & Peel, N. F. A. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2255-8 · Cited by 16
Ripps, B. A., VanGilder, K., Minhas, B. S., Welford, M., & Mamish, Z. (2003) · PubMed · Cited by 15
Shapiro, C. L. (2013) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2013.07.037 · Cited by 14
Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
Clarke, B. L. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79318-7 · Cited by 14
Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer
Varsavsky, M., Reyes‐García, R., Berdonces, M. C., García‐Martin, A., Rozas-Moreno, P., & Muñoz‐Torres, M. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.07.007 · Cited by 12
Application of aromatase inhibitors in endocrine responsive breast cancers
Goss, P. E., & Wu, M. D. (2007) · The Breast · doi:10.1016/j.breast.2007.07.011 · Cited by 10
Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use
Yli-Kyyny, T. T., Tamminen, I. S., & Kröger, H. (2010) · Orthopedics · doi:10.3928/01477447-20101021-37 · Cited by 7
Poznak, C. H. V. (2006) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(06)80396-6 · Cited by 5
Vertebral Fracture Assessment: The 2005 ISCD Official Positions
VOKES, T. (2006) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2006.03.007 · Cited by 5
Diagnosis and Treatment of Osteoporosis
Thompson, S. M., & McGovern, P. G. (2011) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000403721.61250.ee · Cited by 4
Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer
Varsavsky, M., Reyes‐García, R., Berdonces, M. C., García‐Martin, A., Rozas-Moreno, P., & Muñoz‐Torres, M. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.11.001 · Cited by 3
Cited by
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
Nguyen, P. L., Alibhai, S. M. H., Basaria, S., D’Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015) · European Urology · doi:10.1016/j.eururo.2014.07.010 · Cited by 831
Smith, M. R., Saad, F., Coleman, R., Shore, N., Fizazi, K., Tombal, B., Miller, K., Sieber, P., Karsh, L., Damião, R., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61226-9 · Cited by 797
Metadata
- Authors
- Gralow, J. R., Biermann, J. S., Farooki, A., Fornier, M. N., Gagel, R. F., Kumar, R., Litsas, G., McKay, R., Podoloff, D. A., Srinivas, S., & Van Poznak, C. H.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2013-08
- Volume
- 11
- Issue
- suppl 3
- Pages
- S-1-S-50
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2139358843
- Cited by
- 412
- References
- 400
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.